Start / Docs Who Lift / The science of myostatin inhibitors glp 1 meds and muscle mass

The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass

28 min • 6 juni 2025

Dr. Grant Tinsley joins the discussion as the body composition expert.
Myostatin is a key regulator of muscle growth.
Wendy Whippete the most jacked muscled up dog
The concern of GLP-1 receptor agonists and muscle mass loss.
Overview of Courage trial looking at semaglutide and trevogrumab and lean mass loss
Upcoming Believe trial coming out (bimagrumab and semaglutide)
Exercise remains crucial for muscle health and function.
MRI data from SURPASS MRI provides new insights into muscle volume changes.
The combination of medications may have varying effects on muscle mass.
Caution is advised regarding the long-term effects of new drugs.
Clinical benefits of medications often outweigh concerns about muscle loss.
Future research will explore the synergy between exercise and medication.

Other docs who lift podcasts with Dr. Grant:

Tirzepatide muscle loss

Lean mass loss and GLP-1 meds

Senaste avsnitt

Clinical vs Anthropometric Obesity

2 juli | 32 min

GLP-1 meds and macular degeneration

23 juni | 34 min

Menopause, MHT, and GLP-1 medicines

12 juni | 28 min

The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass

6 juni | 28 min

Current State of Nutrition Research and MAHA

29 maj | 56 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00